MAPT and Alzheimer disease: Gong’s group firstly found that O-GlcNAcylation level in AD brains was 22% lower than that in normal brain, and hyperphosphorylated tau contained four-fold less O-GlcNAc than non-hyperphosphorylated tau [8,9].